MedTrace Logo

Shiatsu Adjuvant Therapy And Placebo For Schizophrenia

NCT00788970 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2009-01-13

No results posted yet for this study

Summary

In the current study we will study the effect of adding acupressure (shiatsu) to conventional therapy in treating individuals with schizophrenia.

Conditions

Interventions

BEHAVIORAL

Acupressure adjuvant therapy

Acupressure provided in 40-minute sessions, twice a week for 4 weeks. For placebo acupressure, different meridian points will be used.

Sponsors & Collaborators

  • Herzog Hospital

    lead OTHER

Principal Investigators

  • Pesach Lichtenberg, M.D. · Herzog Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00788970 on ClinicalTrials.gov